OncLive – Clinical Oncology News, Cancer Expert Insights
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Related Articles
Jen Brock Memorial Award | IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and…
FDA Clears ZEISS INTRABEAM 700 for Intraoperative Radiation Therapy in Neuro-Oncology & Breast Cancer
The ZEISS INTRABEM 700 platform received 510(k) clearance from the FDA for use in neuro-oncology and breast cancer surgery.
CAR T-Cell Therapy for Solid Tumors: Leveraging Lessons From Hematologic Malignancies
As we plan for a future with solid tumor CAR T-cell therapy, we should be mindful of lessons learned from CAR T-cell agents for hematologic…
Daraxonrasib Generates Clinical Activity With Manageable Safety in RAS-Mutant NSCLC
Daraxonrasib was safe and active in the pretreated advanced non–small cell lung cancer harboring RAS mutations.
FDA Approves Nivolumab Plus Ipilimumab for dMMR/MSI-H Metastatic CRC
The FDA has granted approval to nivolumab plus ipilimumab for the treatment of patients with dMMR/MSI-H metastatic colorectal cancer.
Tambiciclib Generates Potential OS Benefit in R/R AML
Tambiciclib generated a median overall survival of 8.8 months in patients with relapsed/refractory acute myeloid leukemia.
FDA Approval Is Sought for Ziftomenib in NMP1-Mutant R/R AML
The FDA has received an NDA for ziftomenib in relapsed/refractory NMP1-mutant acute myeloid leukemia.
The OncFive: Top Oncology Articles for the Week of 4/20
Penpulimab gets green light from FDA for nasopharyngeal carcinoma, sacituzumab govitecan combination boosts PFS in TNBC, and more.
Advancing Brain Metastases Research and Mentorship in Breast Oncology: With D. Ross Camidge, MD, PhD; Nancy U. Lin, MD
Drs Camidge and Lin discussed Dr Lin’s work with brain metastases and her role in developing targeted therapies for breast cancer.